Literature DB >> 31542218

Autoimmune diseases and pregnancy.

Angela Tincani1, Cecilia Nalli2, Jamilya Khizroeva3, Victoria Bitsadze3, Andrea Lojacono4, Laura Andreoli2, Yehuda Shoenfeld5, Alexander Makatsariya3.   

Abstract

Pregnancy in autoimmune diseases remains an argument of debate. In last years great improvements were done and with the correct medical support women with disease such as Systemic Lupus Erythematosus or Antiphospholipid Syndrome can afford a pregnancy and have healthy babies. The starting point is a good counselling. Women should be informed about risks that can occur taking some medications while pregnant and, on the other hand, that there are medications that can be safety assumed during pregnancy. Furthermore, there are known maternal risks factor such as the presence of antiphospholipid antibodies or anti-Ro/SSA antibodies that must be carefully manage by both rheumatologists and obstetrics. In addition, also disease activity during pregnancy can represent an issue. For all these reason, a multidisciplinary approach is mandatory in order to give our patients an optimal medical support, before, during and after pregnancy.
Copyright © 2019. Published by Elsevier Ltd.

Entities:  

Keywords:  autoimmune diseases; pregnancy; systematic review

Year:  2019        PMID: 31542218     DOI: 10.1016/j.beem.2019.101322

Source DB:  PubMed          Journal:  Best Pract Res Clin Endocrinol Metab        ISSN: 1521-690X            Impact factor:   4.690


  5 in total

Review 1.  Comparison of treatments for the prevention of fetal growth restriction in obstetric antiphospholipid syndrome: a systematic review and network meta-analysis.

Authors:  Maria Letizia Urban; Alessandra Bettiol; Irene Mattioli; Alfredo Vannacci; Elena Silvestri; Domenico Prisco; Giacomo Emmi; Gerardo Di Scala; Laura Avagliano; Niccolò Lombardi; Giada Crescioli; Gianni Virgili; Caterina Serena; Federico Mecacci; Claudia Ravaldi
Journal:  Intern Emerg Med       Date:  2021-01-21       Impact factor: 3.397

2.  Pregnancy-associated thrombotic thrombocytopenic purpura complicated by Sjögren's syndrome and non-neutralising antibodies to ADAMTS13: a case report.

Authors:  Lu Zhou; Yu Zhu; Miao Jiang; Min Su; Hong Liu; Jian Su; Xiaofan Liu; Yizhi Jiang; Hui Mu; Jie Yin; Li Yang; Haiyan Liu; Weidong Pan
Journal:  BMC Pregnancy Childbirth       Date:  2021-12-03       Impact factor: 3.007

Review 3.  Beyond Systemic Lupus Erythematosus and Anti-Phospholipid Syndrome: The Relevance of Complement From Pathogenesis to Pregnancy Outcome in Other Systemic Rheumatologic Diseases.

Authors:  Silvia Cavalli; Paola Adele Lonati; Maria Gerosa; Roberto Caporali; Rolando Cimaz; Cecilia Beatrice Chighizola
Journal:  Front Pharmacol       Date:  2022-02-15       Impact factor: 5.810

4.  Clinical study of factors associated with pregnancy outcomes in pregnant women with systemic lupus erythematosus in the southern China.

Authors:  Ke Zhang; Chunmei He; Qiaoting Deng; Wengen Li; Zhixiong Zhong; Jingyuan Hou
Journal:  Arch Rheumatol       Date:  2021-10-18       Impact factor: 1.007

5.  Does Adjusted Global Antiphospholipid Syndrome Score (aGAPSS) Predict the Obstetric Outcome in Antiphospholipid Antibody Carriers? A Single-Center Study.

Authors:  Sara Del Barrio-Longarela; Víctor M Martínez-Taboada; Pedro Blanco-Olavarri; Ana Merino; Leyre Riancho-Zarrabeitia; Alejandra Comins-Boo; Marcos López-Hoyos; José L Hernández
Journal:  Clin Rev Allergy Immunol       Date:  2021-12-15       Impact factor: 10.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.